moksha8 sees profit Last week's series D financing and deal with Watson Pharmaceuticals Inc. (NYSE:WPI), has given specialty pharma moksha8 Pharmaceuticals Inc. its first branded generic products and enough cash to get it to profitability,...

Watson will manufacture and supply 12 undisclosed products to moksha8, which will have exclusive rights to market, sell and distribute these products in Brazil and Mexico. Watson will continue to own all marketing authorizations, but...